You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Details for Patent: 10,112,903


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,112,903
Title:Heterocyclic compounds for the treatment of neurological and psychological disorders
Abstract: Lactam compounds of Formula I and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed. ##STR00001##
Inventor(s): Remenar; Julius F. (Framingham, MA), Blumberg; Laura Cook (Lincoln, MA), Zeidan; Tarek A. (Watertown, MA)
Assignee: ALKERMES PHARMA IRELAND LIMITED (Dublin, IE)
Application Number:15/875,478
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,112,903: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 10,112,903, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim[2].

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be significant metrics for measuring patent scope. Independent claim length and count can indicate the breadth and complexity of the patent, influencing factors such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

The Enablement Requirement

The enablement requirement, as outlined in 35 U.S.C. ยง 112, is a critical aspect of patent law. It mandates that a patent applicant must describe the invention in such clear and complete terms that a person skilled in the art can make and use the invention. Recent Supreme Court rulings, such as Amgen Inc. v. Sanofi, have emphasized the importance of this requirement, particularly for broad functional claims[5].

Patent 10,112,903: An Overview

To analyze the scope and claims of United States Patent 10,112,903, we need to examine the patent document itself.

Claim Structure

  • Independent Claims: These claims define the core of the invention and are typically broader in scope.
  • Dependent Claims: These claims build upon the independent claims, often adding specific details or limitations.

Claim Language

The language used in the claims is crucial. Clear and concise language helps in understanding the scope of the invention, while ambiguous language can lead to disputes and litigation.

Enablement and Specification

The patent specification must enable a person skilled in the art to make and use the entire scope of the invention as defined by its claims. This includes detailed descriptions, drawings, and any necessary examples or experiments.

Government Interest and Funding

Many patents, especially those in the fields of health and technology, are developed with government support. For instance, patents granted between 1976 and 2019 often included government interest statements, indicating funding from agencies like the National Institutes of Health or the Department of Agriculture[1].

Geographic Distribution of Inventions

While the patent may be filed in the United States, the invention itself may have been developed elsewhere. Geographic data can provide insights into where inventors are most active and whether there are preferences for filing patents in home countries rather than in the U.S.[4].

Patent Scope Metrics

Metrics such as independent claim length and count can provide quantitative insights into the scope of the patent. These metrics have been validated to have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations[3].

Forward Citations

Forward citations indicate how often a patent is cited by later patents, which can be a measure of its impact and relevance in the field.

Patent Maintenance Payments

The number of maintenance payments made to keep a patent in force can also reflect its value and scope.

Litigation and Validity

The validity of a patent can be challenged based on several grounds, including the enablement requirement. Recent court decisions have set precedents that courts and the USPTO must closely evaluate whether the scope of the claims is consistent with the scope of the specification[5].

Impact on Innovation

Broad or overly broad patents can diminish incentives for innovation by increasing licensing and litigation costs. Narrower claims, on the other hand, are associated with a higher probability of grant and a shorter examination process[3].

Key Takeaways

  • Clear Claims: Clear and concise claim language is essential for defining the scope of the invention.
  • Enablement Requirement: The patent specification must enable a person skilled in the art to make and use the entire scope of the invention.
  • Metrics for Scope: Independent claim length and count are useful metrics for measuring patent scope.
  • Geographic Distribution: Understanding where inventions are developed can provide insights into global innovation trends.
  • Litigation and Validity: The validity of a patent can be challenged based on several grounds, including the enablement requirement.

FAQs

Q: What is the importance of the enablement requirement in patent law?

The enablement requirement ensures that a patent applicant describes the invention in such clear and complete terms that a person skilled in the art can make and use the invention, preventing overly broad claims that do not provide sufficient detail.

Q: How do independent claim length and count affect patent scope?

Independent claim length and count are metrics that can indicate the breadth and complexity of a patent. They have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations.

Q: What role does government funding play in patent development?

Government funding, as indicated by government interest statements, is significant in many patents, especially in fields like health and technology. This funding can come from agencies such as the National Institutes of Health or the Department of Agriculture.

Q: How does the geographic distribution of inventions impact patent filings?

The geographic distribution of inventions can indicate where inventors are most active and whether there are preferences for filing patents in home countries rather than in the U.S.

Q: What are the implications of broad functional claims on innovation?

Broad functional claims can increase licensing and litigation costs, potentially diminishing incentives for innovation. Narrower claims are generally associated with a higher probability of grant and a shorter examination process.

Sources

  1. PatentsView Government Interest Results Analysis - https://patentsview.org/government-interest/results-analysis
  2. Patent Claims Research Dataset - USPTO - https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  3. Patent Claims and Patent Scope - SSRN - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Mining USPTO full text patent data - An exploratory analysis of ... - https://www.alexejgossmann.com/patents_part_1/
  5. Supreme Court Issues Patent Ruling Curbing Broad Functional Claims in Patents - https://www.vorys.com/publication-supreme-court-issues-patent-ruling-curbing-broad-functional-claims-in-patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,112,903

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alkermes Inc ARISTADA aripiprazole lauroxil SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207533-001 Oct 5, 2015 RX Yes No 10,112,903 ⤷  Subscribe Y TREATMENT OF SCHIZOPHRENIA ⤷  Subscribe
Alkermes Inc ARISTADA aripiprazole lauroxil SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207533-002 Oct 5, 2015 RX Yes No 10,112,903 ⤷  Subscribe Y TREATMENT OF SCHIZOPHRENIA ⤷  Subscribe
Alkermes Inc ARISTADA aripiprazole lauroxil SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207533-003 Oct 5, 2015 RX Yes Yes 10,112,903 ⤷  Subscribe Y TREATMENT OF SCHIZOPHRENIA ⤷  Subscribe
Alkermes Inc ARISTADA aripiprazole lauroxil SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 207533-004 Jun 5, 2017 RX Yes No 10,112,903 ⤷  Subscribe Y TREATMENT OF SCHIZOPHRENIA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.